DC
SUPN icon

Deere & Company’s Supernus Pharmaceuticals SUPN Stock Holding History

Deere & Company’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-32,420
Closed -$436K – 1174
2015
Q4 		$436K Hold
32,420
– – 0.03% 621
2015
Q3 		$455K Hold
32,420
– – 0.03% 591
2015
Q2 		$550K Sell
32,420
-25,829
-44% -$368K 0.03% 607
2015
Q1 		$704K Buy
+58,249
New +$550K 0.04% 505

Other funds holding SUPN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return

Deere & Company's SUPN Position: Q1 2016 in Review

Deere & Company sold out of Supernus Pharmaceuticals (SUPN) in Q1 2016, closing a stake of 32,420 shares — an estimated $436K sold.

Deere & Company first reported a position in SUPN in Q1 2015 and held it in 4 quarters. The position peaked at $704K in Q1 2015. 213 funds tracked by Wall St. Rank hold SUPN as of Q1 2016.

  • Deere & Company reported no remaining Supernus Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Deere & Company sold 32,420 Supernus Pharmaceuticals shares in Q1 2016, an estimated $436K.
  • Deere & Company first reported a position in Supernus Pharmaceuticals in Q1 2015 and held it in 4 quarters.
  • Deere & Company's Supernus Pharmaceuticals position peaked at $704K in Q1 2015.
  • 213 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2016.

Based on Deere & Company's 13F filing for Q1 2016, filed 9 May 2016.